Delivery Order SPE2DB20D2014-SPE2DB25FC19U
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,872.20 for the supply of Ketorolac 30 mg/mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and expiring in December 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.76 firm fixed-price delivery order contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,163.76, is a Firm Fixed Price Delivery Order for the supply of Ketorolac 30 mg/ml vials. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,939.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4568105691 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed-price pricing type and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order valued at $2,909.40 with a firm fixed price and an ultimate completion date of June 11, 2025. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,375.34 firm fixed-price delivery order is for the supply of 4,566,777,822 units of 30 mg/mL ketorolac vials. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.76 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,172.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Ketorolac 60 mg/2 ml vials, a pharmaceutical product, with a performance period extending to March 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,909.40, is for the delivery of 4567643017 - Ketorolac 30 mg/ml vial, a pain management medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Ketorolac 30 mg/ml vials, a prescription medication. The contract has a ceiling value of $1,326.96 and is a firm-fixed-price delivery order with a completion date of May 28, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial Indefinite...